While a single BRIP1 PV was detected, this gene is not convincingly associated with breast cancer risk and the current evidence does not support actionability for these variants.27 Similarly there has been no clinical validation for RECQL28 29 and RAD50 and the cases in the current series was consistent with population frequencies. This evidence concerns the gene RAD50 and breast cancer.